Skip to main content

Advertisement

Table 3 The prognostic significance of ABO blood type in different subgroups of ENKTL patients

From: Prognostic role of ABO blood type in patients with extranodal natural killer/T cell lymphoma, nasal type: a triple-center study

Subgroup 5-year OS rate (%) P
Blood type O Blood type non-O
Ann Arbor stage
 I/II 66.1 53.2 0.002
 III/IV 30.6 12.1 0.151
Treatment modality
 CT combined RT 74.5 57.2 0.003
 CT alone 37.7 30.2 0.158
 RT alone 56.7 55.5 0.352
Chemotherapy regimen
 Anthracyclines-containing 59.4 42.8 0.010
 l-Asparaginase-containing 80.6 62.3 0.011
  1. OS overall survival, CT chemotherapy, RT radiotherapy